Home » The Race is On: Ciphergen and Bruker Battle for a Stake in Biomarkers Arena

The Race is On: Ciphergen and Bruker Battle for a Stake in Biomarkers Arena

Sep 05, 2003
Premium

Ciphergen was the first off the starting block in the race to develop biomarker discovery tools, but now, Bruker Daltonics is trying to beat it to the finish line.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Yep, Couple of Concerns There

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

Passing on Trauma, Maybe

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

Told to Pause

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

This Week in PNAS

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.

What's Popular?

In Proteomics & Protein Research

  1. Proteogenomic Approach Identifies Candidate Tumor-Specific Antigens for Immunotherapies

  2. Nanoparticle Enrichment Could Enhance Plasma Protein Biomarker Discovery

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.